Breast Cancer

Surgical choices are difficult, but being informed helps make them easier.

A cancer diagnosis can evoke many emotions. It may, indeed, be too much to grasp.

Catching this bug of helping patients with cancer just may be the healthiest thing you can do.

AstraZeneca highlights important facts about metastatic breast cancer.

Cancer causes changes, but it doesn't change identity.

CURE spoke with an expert on the future of treating triple-negative breast cancer, including the potential for immunotherapy, targeted therapy and AR-targeted agents.

Anti-androgen therapies may eventually be used to treat some patients with breast cancer, according to Tiffany A. Traina, M.D.

Optimizing treatment for patients with HR-positive breast cancer means that researchers must first find a way for patients to overcome drug resistance, says William J. Gradishar, M.D.

Forget advice, forget the stories of others with cancer, and leave silence behind you when you learn about a friend's cancer diagnosis

A former competitive runner discovers the healing link between mastectomies, meditation and marathons.

Art therapy provides a creative outlet for many breast cancer patients and helps them cope with stress.

Three words no one wants to hear

As a survivor of cancer, life has enough difficulty without daily painful reminders. Let go of items that create emotional clutter today.

Does the fear of recurrence ever truly end for a breast cancer survivor and how do we negate its power over us?

Confronted by a simple question, this cancer patient finds a new perspective on health.

Vertical motion helps stimulate the lymphatic system aiding in the disbursement of lymphatic fluid.

What does it feel like when a friend with metastatic cancer learns that cancer has spread again?

Breast cancer and melanoma survivor works on resilience to cope with her two cancers.

This male breast cancer survivor spent a year in residence in a Zen Buddhist Temple. Then he got cancer. Here’s what he learned.

Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.